Portunus trituberculatus isolate SZX2019 chromosome 14, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030084.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC123503605, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123503605, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123503605, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123503605, transcript variant X3
uncharacterized LOC123503605, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
piggyBac transposable element-derived protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123503404, transcript variant X1
uncharacterized LOC123503404, transcript variant X5
uncharacterized LOC123503404, transcript variant X4
uncharacterized LOC123503404, transcript variant X6
uncharacterized LOC123503404, transcript variant X3
uncharacterized LOC123503404, transcript variant X2
uncharacterized protein LOC123503404 isoform X4
uncharacterized protein LOC123503404 isoform X3
uncharacterized protein LOC123503404 isoform X5
uncharacterized protein LOC123503404 isoform X2
uncharacterized protein LOC123503404 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123503732, transcript variant X1
uncharacterized LOC123503732, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
neurogenic locus protein delta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neurogenic locus protein delta-like, transcript variant X3
neurogenic locus protein delta-like, transcript variant X1
uncharacterized LOC123503517, transcript variant X1
uncharacterized LOC123503517, transcript variant X2
histone-lysine N-methyltransferase 2D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123503493, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC123503493, transcript variant X3
uncharacterized LOC123503493, transcript variant X1
uncharacterized LOC123503497, transcript variant X1
uncharacterized LOC123503497, transcript variant X2
uncharacterized protein LOC123503497 isoform X1
uncharacterized protein LOC123503497 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503502, transcript variant X3
uncharacterized LOC123503502, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123503502, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123503502, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC123503502 isoform X1
uncharacterized protein LOC123503502 isoform X3
uncharacterized protein LOC123503502 isoform X2
uncharacterized LOC123503514, transcript variant X1
uncharacterized LOC123503514, transcript variant X2
uncharacterized LOC123503514, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503505, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123503505, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123503505, transcript variant X2
uncharacterized LOC123503505, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123503505, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein LOC123503505 isoform X1
uncharacterized protein LOC123503505 isoform X3
uncharacterized protein LOC123503505 isoform X2
serine proteinase stubble-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine proteinase stubble-like, transcript variant X2
uncharacterized protein LOC123503498 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
serine proteinase stubble-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
serine proteinase stubble-like, transcript variant X4
serine proteinase stubble-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
serine proteinase stubble-like isoform X3
serine/arginine repetitive matrix protein 1-like isoform X2
uncharacterized LOC123503509, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC123503509, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123503513, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123503513, transcript variant X3
uncharacterized LOC123503513, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123503513, transcript variant X2
uncharacterized LOC123503513, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/arginine repetitive matrix protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/arginine repetitive matrix protein 1-like, transcript variant X2
serine/arginine repetitive matrix protein 1-like, transcript variant X3
serine/arginine repetitive matrix protein 1-like, transcript variant X5
serine/arginine repetitive matrix protein 1-like, transcript variant X4
serine/arginine repetitive matrix protein 1-like, transcript variant X6
uncharacterized protein LOC123503501 isoform X2
uncharacterized protein LOC123503501 isoform X3
serine/arginine repetitive matrix protein 1-like isoform X1
uncharacterized LOC123503515, transcript variant X1
uncharacterized LOC123503515, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC123503503 isoform X2
uncharacterized protein LOC123503503 isoform X3
uncharacterized LOC123503499, transcript variant X1
uncharacterized LOC123503499, transcript variant X2
uncharacterized LOC123503499, transcript variant X6
uncharacterized LOC123503499, transcript variant X5
uncharacterized LOC123503499, transcript variant X3
uncharacterized LOC123503499, transcript variant X4
uncharacterized protein LOC123503499 isoform X1
uncharacterized protein LOC123503499 isoform X2
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123503746, transcript variant X2
uncharacterized LOC123503746, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503695, transcript variant X3
uncharacterized LOC123503695, transcript variant X1
uncharacterized LOC123503695, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123503686, transcript variant X2
uncharacterized LOC123503686, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123503685, transcript variant X2
uncharacterized LOC123503685, transcript variant X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2-like, transcript variant X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2-like, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2-like
uncharacterized LOC123503599, transcript variant X2
uncharacterized LOC123503599, transcript variant X1
uncharacterized LOC123503599, transcript variant X3
uncharacterized LOC123503599, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123503599, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC123503361, transcript variant X2
similar to RNA sequence (same species):INSD:GFFJ01063465.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 2441 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC123503361, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 2441 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 68 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 405 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized protein LOC123503361 isoform X2
uncharacterized protein LOC123503361 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
enoyl-CoA delta isomerase 2-like, transcript variant X2
enoyl-CoA delta isomerase 2-like, transcript variant X4
enoyl-CoA delta isomerase 2-like, transcript variant X9
enoyl-CoA delta isomerase 2-like, transcript variant X5
enoyl-CoA delta isomerase 2-like, transcript variant X3
enoyl-CoA delta isomerase 2-like, transcript variant X6
enoyl-CoA delta isomerase 2-like, transcript variant X1
enoyl-CoA delta isomerase 2-like, transcript variant X7
enoyl-CoA delta isomerase 2-like, transcript variant X8
enoyl-CoA delta isomerase 2-like isoform X4
enoyl-CoA delta isomerase 2-like isoform X1
enoyl-CoA delta isomerase 2-like isoform X2
enoyl-CoA delta isomerase 2-like isoform X3
enoyl-CoA delta isomerase 2-like isoform X5
mRNA-capping enzyme-like, transcript variant X3
mRNA-capping enzyme-like, transcript variant X2
mRNA-capping enzyme-like, transcript variant X1
attractin-like protein 1, transcript variant X1
attractin-like protein 1, transcript variant X2
DNA repair endonuclease XPF-like, transcript variant X3
DNA repair endonuclease XPF-like, transcript variant X4
DNA repair endonuclease XPF-like, transcript variant X1
DNA repair endonuclease XPF-like, transcript variant X2
DNA repair endonuclease XPF-like, transcript variant X6
DNA repair endonuclease XPF-like isoform X2
DNA repair endonuclease XPF-like isoform X3
DNA repair endonuclease XPF-like isoform X1
DNA repair endonuclease XPF-like isoform X5
DNA repair endonuclease XPF-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA repair endonuclease XPF-like isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
zinc finger BED domain-containing protein 5-like
probable signal peptidase complex subunit 2, transcript variant X1
probable signal peptidase complex subunit 2, transcript variant X2
probable signal peptidase complex subunit 2, transcript variant X3
probable signal peptidase complex subunit 2 isoform X1
probable signal peptidase complex subunit 2 isoform X2
probable signal peptidase complex subunit 2 isoform X3
putative sodium-coupled neutral amino acid transporter 7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: forkhead box protein O-like
uncharacterized LOC123503738, transcript variant X6
uncharacterized LOC123503738, transcript variant X3
uncharacterized LOC123503738, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123503738, transcript variant X1
uncharacterized LOC123503738, transcript variant X4
uncharacterized LOC123503738, transcript variant X5
growth factor receptor-bound protein 2, transcript variant X4
growth factor receptor-bound protein 2, transcript variant X1
growth factor receptor-bound protein 2, transcript variant X2
growth factor receptor-bound protein 2, transcript variant X3
growth factor receptor-bound protein 2 isoform X1
growth factor receptor-bound protein 2 isoform X2
cilia- and flagella-associated protein 251-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
PAX-interacting protein 1-like, transcript variant X1
PAX-interacting protein 1-like, transcript variant X2
PAX-interacting protein 1-like isoform X1
PAX-interacting protein 1-like isoform X2
programmed cell death protein 6-like, transcript variant X1
programmed cell death protein 6-like, transcript variant X3
programmed cell death protein 6-like, transcript variant X2
programmed cell death protein 6-like isoform X2
programmed cell death protein 6-like isoform X1
uncharacterized LOC123503873, transcript variant X2
uncharacterized LOC123503873, transcript variant X1
protein TRACHEARY ELEMENT DIFFERENTIATION-RELATED 7A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
glycine-rich cell wall structural protein 1-like
uncharacterized protein DDB_G0271670-like, transcript variant X1
uncharacterized protein DDB_G0271670-like, transcript variant X2
uncharacterized protein DDB_G0271670-like isoform X1
uncharacterized protein DDB_G0271670-like isoform X2
26S proteasome regulatory subunit 8, transcript variant X2
26S proteasome regulatory subunit 8 isoform X2
26S proteasome regulatory subunit 8, transcript variant X1
26S proteasome regulatory subunit 8 isoform X1
retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta-like
28S ribosomal protein S35, mitochondrial-like
uncharacterized LOC123503636, transcript variant X2
uncharacterized LOC123503636, transcript variant X1
uncharacterized protein LOC123503636 isoform X1
uncharacterized LOC123503636, transcript variant X4
uncharacterized LOC123503636, transcript variant X3
uncharacterized protein LOC123503636 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
kelch domain-containing protein 3-like, transcript variant X2
kelch domain-containing protein 3-like, transcript variant X3
kelch domain-containing protein 3-like, transcript variant X1
leucine-rich repeat protein SHOC-2-like, transcript variant X1
leucine-rich repeat protein SHOC-2-like, transcript variant X2
leucine-rich repeat protein SHOC-2-like isoform X1
leucine-rich repeat-containing protein 40-like isoform X2
zinc finger protein Xfin-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123503369 isoform X7
zinc finger protein Xfin-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC123503369 isoform X5
zinc finger protein Xfin-like, transcript variant X1
zinc finger protein Xfin-like, transcript variant X2
uncharacterized protein LOC123503369 isoform X1
zinc finger protein Xfin-like isoform X2
zinc finger protein Xfin-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC123503369 isoform X8
zinc finger protein Xfin-like, transcript variant X6
uncharacterized protein LOC123503369 isoform X6
zinc finger protein Xfin-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein Xfin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC123503369 isoform X4
uncharacterized protein LOC123503369 isoform X3
zinc finger protein Xfin-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC123503656, transcript variant X2
uncharacterized LOC123503656, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC123503656 isoform X2
uncharacterized protein LOC123503656 isoform X1
signal peptide, CUB and EGF-like domain-containing protein 1, transcript variant X5
signal peptide, CUB and EGF-like domain-containing protein 1 isoform X2
signal peptide, CUB and EGF-like domain-containing protein 1, transcript variant X3
signal peptide, CUB and EGF-like domain-containing protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
signal peptide, CUB and EGF-like domain-containing protein 1, transcript variant X1
signal peptide, CUB and EGF-like domain-containing protein 1, transcript variant X4
signal peptide, CUB and EGF-like domain-containing protein 1, transcript variant X2
signal peptide, CUB and EGF-like domain-containing protein 1 isoform X1
ribose-5-phosphate isomerase-like, transcript variant X1
ribose-5-phosphate isomerase-like, transcript variant X2
ribose-5-phosphate isomerase-like, transcript variant X4
ribose-5-phosphate isomerase-like, transcript variant X3
ribose-5-phosphate isomerase-like isoform X1
ribose-5-phosphate isomerase-like isoform X2
uncharacterized LOC123503386, transcript variant X1
uncharacterized LOC123503386, transcript variant X2
uncharacterized protein LOC123503386 isoform X1
uncharacterized protein LOC123503386 isoform X2
uncharacterized LOC123503386, transcript variant X3
uncharacterized protein LOC123503386 isoform X3
DNA excision repair protein ERCC-8-like, transcript variant X4
DNA excision repair protein ERCC-8-like, transcript variant X1
DNA excision repair protein ERCC-8-like, transcript variant X3
DNA excision repair protein ERCC-8-like, transcript variant X2
propionyl-CoA carboxylase alpha chain, mitochondrial-like
LOW QUALITY PROTEIN: propionyl-CoA carboxylase alpha chain, mitochondrial-like
uncharacterized LOC123503678, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123503678, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123503678, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123503678, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123503678, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123503678, transcript variant X3
uncharacterized LOC123503678, transcript variant X6
uncharacterized LOC123503678, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC123503678 isoform X2
uncharacterized protein LOC123503678 isoform X1
uncharacterized protein LOC123503678 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123503593, transcript variant X1
uncharacterized LOC123503593, transcript variant X2
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
heat shock factor-binding protein 1-like
cytochrome c oxidase assembly factor 6 homolog, transcript variant X2
cytochrome c oxidase assembly factor 6 homolog, transcript variant X1
cytochrome c oxidase assembly factor 6 homolog isoform X1
cytochrome c oxidase assembly factor 6 homolog isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
protein slowmo-like, transcript variant X1
protein slowmo-like, transcript variant X2
galactosylceramide sulfotransferase-like, transcript variant X1
galactosylceramide sulfotransferase-like, transcript variant X2
galactosylceramide sulfotransferase-like isoform X1
galactosylceramide sulfotransferase-like isoform X2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123503375, transcript variant X2
uncharacterized LOC123503375, transcript variant X1
4-coumarate--CoA ligase 1-like, transcript variant X2
4-coumarate--CoA ligase 1-like, transcript variant X1
4-coumarate--CoA ligase 1-like, transcript variant X3
ER lumen protein-retaining receptor 2-like
transcription elongation regulator 1-like, transcript variant X2
transcription elongation regulator 1-like, transcript variant X4
transcription elongation regulator 1-like, transcript variant X1
transcription elongation regulator 1-like, transcript variant X3
transcription elongation regulator 1-like isoform X1
transcription elongation regulator 1-like isoform X2
transcription elongation regulator 1-like isoform X3
transcription elongation regulator 1-like isoform X4
general transcription factor IIF subunit 1-like
neural-cadherin-like, transcript variant X1
neural-cadherin-like, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
neural-cadherin-like, transcript variant X3
uncharacterized LOC123503548, transcript variant X5
uncharacterized LOC123503548, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123503548, transcript variant X4
uncharacterized LOC123503548, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123503548, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein jim lovell-like, transcript variant X5
protein jim lovell-like, transcript variant X6
protein jim lovell-like, transcript variant X1
protein jim lovell-like, transcript variant X2
protein jim lovell-like, transcript variant X4
protein jim lovell-like, transcript variant X7
protein jim lovell-like, transcript variant X3
protein jim lovell-like, transcript variant X8
protein jim lovell-like, transcript variant X9
uncharacterized protein LOC123503551 isoform X1
uncharacterized protein LOC123503551 isoform X2
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
tetraspanin-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tetraspanin-3-like, transcript variant X1
histone-lysine N-methyltransferase SETD1B-like
disks large 1 tumor suppressor protein-like, transcript variant X2
disks large 1 tumor suppressor protein-like, transcript variant X6
disks large 1 tumor suppressor protein-like, transcript variant X1
disks large 1 tumor suppressor protein-like, transcript variant X4
disks large 1 tumor suppressor protein-like, transcript variant X5
disks large 1 tumor suppressor protein-like, transcript variant X3
disks large 1 tumor suppressor protein-like isoform X1
disks large 1 tumor suppressor protein-like isoform X2
disks large 1 tumor suppressor protein-like isoform X5
disks large 1 tumor suppressor protein-like isoform X4
disks large 1 tumor suppressor protein-like isoform X3
disks large 1 tumor suppressor protein-like, transcript variant X7
discs large homolog 1-like protein isoform X6
uncharacterized LOC123503558, transcript variant X1
uncharacterized LOC123503558, transcript variant X3
uncharacterized LOC123503558, transcript variant X2
uncharacterized protein LOC123503558 isoform X1
uncharacterized protein LOC123503558 isoform X2
uncharacterized protein LOC123503558 isoform X3
uncharacterized LOC123503619, transcript variant X2
uncharacterized LOC123503619, transcript variant X1
uncharacterized LOC123503619, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kyphoscoliosis peptidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kyphoscoliosis peptidase-like, transcript variant X2
kyphoscoliosis peptidase-like isoform X1
kyphoscoliosis peptidase-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: beta-galactosidase-1-like protein 2
neuronal acetylcholine receptor subunit alpha-10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503671, transcript variant X10
uncharacterized LOC123503671, transcript variant X13
uncharacterized LOC123503671, transcript variant X8
uncharacterized LOC123503671, transcript variant X4
uncharacterized LOC123503671, transcript variant X6
uncharacterized LOC123503671, transcript variant X3
uncharacterized LOC123503671, transcript variant X14
uncharacterized LOC123503671, transcript variant X2
uncharacterized LOC123503671, transcript variant X15
uncharacterized LOC123503671, transcript variant X9
uncharacterized LOC123503671, transcript variant X5
uncharacterized LOC123503671, transcript variant X16
uncharacterized LOC123503671, transcript variant X17
uncharacterized LOC123503671, transcript variant X12
uncharacterized LOC123503671, transcript variant X1
uncharacterized LOC123503671, transcript variant X11
uncharacterized LOC123503671, transcript variant X7
SET and MYND domain-containing protein 5-like, transcript variant X1
SET and MYND domain-containing protein 5-like, transcript variant X2
SET and MYND domain-containing protein 5-like, transcript variant X3
SET and MYND domain-containing protein 5-like
DNA excision repair protein ERCC-5 homolog
non-lysosomal glucosylceramidase-like, transcript variant X1
non-lysosomal glucosylceramidase-like, transcript variant X2
non-lysosomal glucosylceramidase-like isoform X1
non-lysosomal glucosylceramidase-like isoform X2
mitochondrial translation release factor in rescue-like
kinesin-like protein KIF14, transcript variant X3
kinesin-like protein KIF14, transcript variant X1
kinesin-like protein KIF14, transcript variant X2
bone morphogenetic protein 10-like, transcript variant X2
bone morphogenetic protein 10-like, transcript variant X1
bone morphogenetic protein 10-like, transcript variant X3
bone morphogenetic protein 10-like isoform X1
bone morphogenetic protein 10-like isoform X2
ubiquitin-conjugating enzyme E2 N, transcript variant X1
ubiquitin-conjugating enzyme E2 N, transcript variant X2
ubiquitin-conjugating enzyme E2 N isoform X1
ubiquitin-conjugating enzyme E2 N isoform X2
uncharacterized LOC123503590, transcript variant X1
uncharacterized LOC123503590, transcript variant X3
uncharacterized LOC123503590, transcript variant X2
uncharacterized LOC123503589, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123503589, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123503587, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123503587, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
argininosuccinate lyase-like, transcript variant X2
argininosuccinate lyase-like, transcript variant X1
uncharacterized LOC123503674, transcript variant X1
uncharacterized LOC123503674, transcript variant X2
T-box transcription factor TBX20-like, transcript variant X1
T-box transcription factor TBX20-like, transcript variant X2
T-box transcription factor TBX20-like isoform X1
T-box transcription factor TBX20-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: T-box protein H15-like
calcium-independent phospholipase A2-gamma-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
calcium-independent phospholipase A2-gamma-like isoform X1
calcium-independent phospholipase A2-gamma-like isoform X2
ATP-dependent RNA helicase DHX8-like, transcript variant X2
ATP-dependent RNA helicase DHX8-like, transcript variant X3
ATP-dependent RNA helicase DHX8-like, transcript variant X1
ATP-dependent RNA helicase DHX8-like isoform X2
probable pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH5 isoform X1
afadin- and alpha-actinin-binding protein-like, transcript variant X1
afadin- and alpha-actinin-binding protein-like, transcript variant X2
afadin- and alpha-actinin-binding protein-like isoform X1
afadin- and alpha-actinin-binding protein-like isoform X2
afadin- and alpha-actinin-binding protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
afadin- and alpha-actinin-binding protein-like isoform X3
beta-1,3-galactosyltransferase 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,3-galactosyltransferase 5-like isoform X2
beta-1,3-galactosyltransferase 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
beta-1,3-galactosyltransferase 5-like isoform X1
beta-1,3-galactosyltransferase 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-1,3-galactosyltransferase 5-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
beta-1,3-galactosyltransferase 5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
beta-1,3-galactosyltransferase 5-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
beta-1,3-galactosyltransferase 5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein amalgam-like, transcript variant X1
protein amalgam-like, transcript variant X7
protein amalgam-like, transcript variant X3
protein amalgam-like, transcript variant X2
protein amalgam-like, transcript variant X5
protein amalgam-like, transcript variant X4
protein amalgam-like, transcript variant X6
protein amalgam-like, transcript variant X8
neuroblast differentiation-associated protein AHNAK-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
CCHC-type zinc finger protein CG3800-like, transcript variant X1
CCHC-type zinc finger protein CG3800-like, transcript variant X4
CCHC-type zinc finger protein CG3800-like, transcript variant X2
CCHC-type zinc finger protein CG3800-like, transcript variant X3
cellular nucleic acid-binding protein-like isoform X2
cold shock domain-containing protein 3-like isoform X1
CCHC-type zinc finger protein CG3800-like, transcript variant X5
CCHC-type zinc finger protein CG3800-like isoform X3
uncharacterized LOC123503664, transcript variant X1
uncharacterized LOC123503664, transcript variant X3
uncharacterized LOC123503664, transcript variant X2
uncharacterized LOC123503664, transcript variant X6
uncharacterized LOC123503664, transcript variant X4
uncharacterized LOC123503664, transcript variant X5
uncharacterized protein LOC123503664 isoform X6
uncharacterized protein LOC123503664 isoform X3
uncharacterized protein LOC123503664 isoform X4
uncharacterized protein LOC123503664 isoform X2
uncharacterized protein LOC123503664 isoform X1
uncharacterized protein LOC123503664 isoform X5
zinc finger and BTB domain-containing protein 14-like, transcript variant X1
zinc finger and BTB domain-containing protein 14-like, transcript variant X2
uncharacterized protein LOC123503539 isoform X1
zinc finger and BTB domain-containing protein 14-like isoform X2
E3 SUMO-protein ligase ZBED1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
E3 SUMO-protein ligase ZBED1-like isoform X2
E3 SUMO-protein ligase ZBED1-like, transcript variant X1
E3 SUMO-protein ligase ZBED1-like, transcript variant X3
E3 SUMO-protein ligase ZBED1-like isoform X1
E3 SUMO-protein ligase ZBED1-like isoform X3
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1-like
LOW QUALITY PROTEIN: uncharacterized protein LOC123503485
uncharacterized LOC123503544, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC123503544, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
uncharacterized LOC123503544, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123503367, transcript variant X3
uncharacterized LOC123503367, transcript variant X4
uncharacterized LOC123503367, transcript variant X1
uncharacterized LOC123503367, transcript variant X2
uncharacterized protein LOC123503367 isoform X2
uncharacterized protein LOC123503367 isoform X1
neurogenic protein big brain-like, transcript variant X2
neurogenic protein big brain-like, transcript variant X1
neurogenic protein big brain-like, transcript variant X3
neurogenic protein big brain-like isoform X1
neurogenic protein big brain-like isoform X2
neurogenic protein big brain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
neurogenic protein big brain-like isoform X3
RNA exonuclease 1 homolog, transcript variant X4
RNA exonuclease 1 homolog, transcript variant X2
RNA exonuclease 1 homolog, transcript variant X1
RNA exonuclease 1 homolog, transcript variant X3
uncharacterized LOC123503368, transcript variant X2
uncharacterized LOC123503368, transcript variant X1
uncharacterized LOC123503368, transcript variant X3
uncharacterized LOC123503368, transcript variant X4
peroxisomal targeting signal 1 receptor-like, transcript variant X2
peroxisomal targeting signal 1 receptor-like, transcript variant X1
peroxisomal targeting signal 1 receptor-like
uncharacterized LOC123503836, transcript variant X3
uncharacterized LOC123503836, transcript variant X2
uncharacterized LOC123503836, transcript variant X1
uncharacterized protein LOC123503836 isoform X1
uncharacterized protein LOC123503836 isoform X2
uncharacterized protein LOC123503836 isoform X3
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zwei Ig domain protein zig-8-like isoform X2
uncharacterized protein LOC123503609 isoform X1
zwei Ig domain protein zig-8-like isoform X3
serine/threonine-protein kinase greatwall-like, transcript variant X1
serine/threonine-protein kinase greatwall-like, transcript variant X2
serine/threonine-protein kinase greatwall-like isoform X1
serine/threonine-protein kinase greatwall-like isoform X2
putative zinc metalloproteinase YIL108W, transcript variant X3
putative zinc metalloproteinase YIL108W, transcript variant X4
putative zinc metalloproteinase YIL108W, transcript variant X5
putative zinc metalloproteinase YIL108W, transcript variant X6
putative zinc metalloproteinase YIL108W, transcript variant X2
putative zinc metalloproteinase YIL108W, transcript variant X1
putative zinc metalloproteinase YIL108W isoform X1
putative zinc metalloproteinase YIL108W isoform X3
putative zinc metalloproteinase C607.06c isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123503741
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rhomboid-related protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rhomboid-related protein 1-like, transcript variant X6
rhomboid-related protein 1-like, transcript variant X10
rhomboid-related protein 1-like, transcript variant X7
rhomboid-related protein 1-like, transcript variant X4
rhomboid-related protein 1-like, transcript variant X9
rhomboid-related protein 1-like, transcript variant X11
rhomboid-related protein 1-like, transcript variant X8
rhomboid-related protein 1-like, transcript variant X3
rhomboid-related protein 1-like, transcript variant X1
rhomboid-related protein 1-like, transcript variant X5
rhomboid-related protein 1-like isoform X3
rhomboid-related protein 1-like isoform X1
rhomboid-related protein 1-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
myosin heavy chain, non-muscle-like, transcript variant X1
myosin heavy chain, non-muscle-like, transcript variant X7
myosin heavy chain, non-muscle-like, transcript variant X2
myosin heavy chain, non-muscle-like, transcript variant X3
myosin heavy chain, non-muscle-like, transcript variant X8
myosin heavy chain, non-muscle-like, transcript variant X4
myosin heavy chain, non-muscle-like, transcript variant X5
myosin heavy chain, non-muscle-like, transcript variant X6
myosin heavy chain, non-muscle-like, transcript variant X11
myosin heavy chain, non-muscle-like, transcript variant X9
myosin heavy chain, non-muscle-like, transcript variant X10
myosin heavy chain, non-muscle-like isoform X1
myosin heavy chain, non-muscle-like isoform X7
myosin heavy chain, non-muscle-like isoform X2
myosin heavy chain, non-muscle-like isoform X3
myosin heavy chain, non-muscle-like isoform X8
myosin heavy chain, non-muscle-like isoform X4
myosin heavy chain, non-muscle-like isoform X5
myosin heavy chain, non-muscle-like isoform X6
myosin heavy chain, non-muscle-like isoform X11
myosin heavy chain, non-muscle-like isoform X9
myosin heavy chain, non-muscle-like isoform X10
protein transport protein Sec61 subunit alpha
uncharacterized LOC123503596, transcript variant X2
uncharacterized LOC123503596, transcript variant X1
uncharacterized protein LOC123503596 isoform X1
uncharacterized protein LOC123503596 isoform X2
glutamate receptor ionotropic, delta-2-like
transcription initiation factor TFIID subunit 1-like, transcript variant X3
transcription initiation factor TFIID subunit 1-like, transcript variant X1
transcription initiation factor TFIID subunit 1-like, transcript variant X4
transcription initiation factor TFIID subunit 1-like, transcript variant X2
transcription initiation factor TFIID subunit 1-like isoform X1
transcription initiation factor TFIID subunit 1-like isoform X3
transcription initiation factor TFIID subunit 1-like isoform X2
transcription initiation factor TFIID subunit 1-like isoform X4
transcription initiation factor TFIID subunit 1-like, transcript variant X7
transcription initiation factor TFIID subunit 1-like, transcript variant X5
transcription initiation factor TFIID subunit 1-like, transcript variant X6
transcription initiation factor TFIID subunit 1-like isoform X5
uncharacterized LOC123503463, transcript variant X2
uncharacterized LOC123503463, transcript variant X3
uncharacterized LOC123503463, transcript variant X1
uncharacterized LOC123503466, transcript variant X3
uncharacterized LOC123503466, transcript variant X4
uncharacterized LOC123503466, transcript variant X1
uncharacterized LOC123503466, transcript variant X2
uncharacterized protein LOC123503466 isoform X3
uncharacterized protein LOC123503466 isoform X1
uncharacterized protein LOC123503466 isoform X4
uncharacterized protein LOC123503466 isoform X2
mitochondrial import inner membrane translocase subunit Tim21-like
transient receptor potential channel pyrexia-like, transcript variant X2
transient receptor potential channel pyrexia-like, transcript variant X1
transient receptor potential channel pyrexia-like, transcript variant X3
transient receptor potential channel pyrexia-like isoform X1
transient receptor potential channel pyrexia-like isoform X2
LOW QUALITY PROTEIN: uncharacterized protein LOC123503472
conserved oligomeric Golgi complex subunit 4-like
dnaJ homolog subfamily C member 30, mitochondrial-like
serine/threonine-protein kinase grp-like, transcript variant X3
serine/threonine-protein kinase grp-like, transcript variant X4
serine/threonine-protein kinase grp-like, transcript variant X5
serine/threonine-protein kinase grp-like, transcript variant X1
serine/threonine-protein kinase grp-like, transcript variant X2
serine/threonine-protein kinase grp-like isoform X3
serine/threonine-protein kinase Chk1-like isoform X4
serine/threonine-protein kinase grp-like isoform X1
serine/threonine-protein kinase grp-like isoform X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SET and MYND domain-containing protein 4-like, transcript variant X3
SET and MYND domain-containing protein 4-like, transcript variant X2
SET and MYND domain-containing protein 4-like, transcript variant X4
SET and MYND domain-containing protein 4-like, transcript variant X1
SET and MYND domain-containing protein 4-like, transcript variant X5
SET and MYND domain-containing protein 4-like isoform X2
SET and MYND domain-containing protein 4-like isoform X1
SET and MYND domain-containing protein 4-like isoform X3
hormone receptor 4-like, transcript variant X14
hormone receptor 4-like, transcript variant X10
hormone receptor 4-like, transcript variant X19
hormone receptor 4-like, transcript variant X20
hormone receptor 4-like, transcript variant X11
hormone receptor 4-like, transcript variant X12
hormone receptor 4-like, transcript variant X6
hormone receptor 4-like, transcript variant X7
hormone receptor 4-like, transcript variant X8
hormone receptor 4-like, transcript variant X5
hormone receptor 4-like, transcript variant X17
hormone receptor 4-like, transcript variant X18
hormone receptor 4-like, transcript variant X9
hormone receptor 4-like, transcript variant X13
hormone receptor 4-like, transcript variant X2
hormone receptor 4-like, transcript variant X1
hormone receptor 4-like, transcript variant X15
hormone receptor 4-like, transcript variant X4
hormone receptor 4-like, transcript variant X3
hormone receptor 4-like, transcript variant X16
KICSTOR complex protein kaptin-like, transcript variant X1
KICSTOR complex protein kaptin-like, transcript variant X3
KICSTOR complex protein kaptin-like, transcript variant X2
KICSTOR complex protein kaptin-like isoform X1
KICSTOR complex protein kaptin-like isoform X2
vacuolar protein sorting-associated protein 37B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
vacuolar protein sorting-associated protein 37B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
vacuolar protein sorting-associated protein 37B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
vacuolar protein sorting-associated protein 37B-like isoform X1
vacuolar protein sorting-associated protein 37B-like isoform X2
huntingtin-interacting protein K-like, transcript variant X1
huntingtin-interacting protein K-like, transcript variant X2
tyrosine-protein phosphatase 99A-like, transcript variant X3
tyrosine-protein phosphatase 99A-like isoform X3
tyrosine-protein phosphatase 99A-like, transcript variant X1
tyrosine-protein phosphatase 99A-like, transcript variant X4
tyrosine-protein phosphatase 99A-like, transcript variant X2
tyrosine-protein phosphatase 99A-like isoform X1
tyrosine-protein phosphatase 99A-like isoform X4
tyrosine-protein phosphatase 99A-like isoform X2
uncharacterized LOC123503750, transcript variant X4
uncharacterized LOC123503750, transcript variant X5
uncharacterized LOC123503750, transcript variant X2
uncharacterized LOC123503750, transcript variant X1
uncharacterized LOC123503750, transcript variant X3
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
anaphase-promoting complex subunit 1-like
cyclin-dependent kinases regulatory subunit-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123503384
BTB/POZ domain-containing protein 6-like, transcript variant X3
BTB/POZ domain-containing protein 6-like, transcript variant X2
BTB/POZ domain-containing protein 6-like, transcript variant X1
BTB/POZ domain-containing protein 6-B-like isoform X1
BTB/POZ domain-containing protein 6-like, transcript variant X5
BTB/POZ domain-containing protein 6-like, transcript variant X4
BTB/POZ domain-containing protein 6-like, transcript variant X6
BTB/POZ domain-containing protein 6-like isoform X2
uncharacterized protein LOC123503382 isoform X3
uncharacterized LOC123503385, transcript variant X2
uncharacterized LOC123503385, transcript variant X3
uncharacterized LOC123503385, transcript variant X1
little elongation complex subunit 2-like, transcript variant X1
little elongation complex subunit 2-like, transcript variant X2
little elongation complex subunit 2-like isoform X2
little elongation complex subunit 2-like isoform X1
xanthine dehydrogenase/oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
xanthine dehydrogenase/oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
xanthine dehydrogenase/oxidase-like isoform X1
xanthine dehydrogenase/oxidase-like isoform X2
zinc finger protein 227-like, transcript variant X1
zinc finger protein 227-like, transcript variant X2
zinc finger protein 227-like, transcript variant X4
zinc finger protein 227-like, transcript variant X3
esterase OVCA2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C9orf85 homolog, transcript variant X2
uncharacterized protein C9orf85 homolog, transcript variant X3
uncharacterized protein C9orf85 homolog, transcript variant X1
uncharacterized protein C9orf85 homolog isoform X1
uncharacterized protein C9orf85 homolog isoform X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1, transcript variant X5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 isoform X4
esterase OVCA2-like, transcript variant X9
esterase OVCA2-like, transcript variant X4
esterase OVCA2-like, transcript variant X2
esterase OVCA2-like, transcript variant X5
esterase OVCA2-like, transcript variant X3
esterase OVCA2-like, transcript variant X10
esterase OVCA2-like, transcript variant X7
esterase OVCA2-like, transcript variant X6
esterase OVCA2-like, transcript variant X8
esterase OVCA2-like, transcript variant X11
TIMELESS-interacting protein-like, transcript variant X2
TIMELESS-interacting protein-like, transcript variant X4
TIMELESS-interacting protein-like, transcript variant X1
TIMELESS-interacting protein-like, transcript variant X3
uncharacterized protein LOC123503843 isoform X1
TIMELESS-interacting protein-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: uncharacterized protein LOC123503850
uncharacterized LOC123503841, transcript variant X4
uncharacterized LOC123503841, transcript variant X1
uncharacterized LOC123503841, transcript variant X5
uncharacterized LOC123503841, transcript variant X2
uncharacterized LOC123503841, transcript variant X3
uncharacterized LOC123503841, transcript variant X6
uncharacterized LOC123503841, transcript variant X7
uncharacterized protein LOC123503841 isoform X2
uncharacterized protein LOC123503841 isoform X1
uncharacterized protein LOC123503841 isoform X3
ankyrin repeat and LEM domain-containing protein 1-like
LOW QUALITY PROTEIN: ankyrin repeat and LEM domain-containing protein 1-like
sodium-coupled monocarboxylate transporter 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium-coupled monocarboxylate transporter 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sodium-coupled monocarboxylate transporter 2-like
1-phosphatidylinositol 3-phosphate 5-kinase-like, transcript variant X1
1-phosphatidylinositol 3-phosphate 5-kinase-like, transcript variant X5
1-phosphatidylinositol 3-phosphate 5-kinase-like, transcript variant X3
1-phosphatidylinositol 3-phosphate 5-kinase-like, transcript variant X2
1-phosphatidylinositol 3-phosphate 5-kinase-like, transcript variant X4
1-phosphatidylinositol 3-phosphate 5-kinase-like isoform X1
1-phosphatidylinositol 3-phosphate 5-kinase-like isoform X3
1-phosphatidylinositol 3-phosphate 5-kinase-like isoform X2
1-phosphatidylinositol 3-phosphate 5-kinase-like isoform X4
probable tRNA (uracil-O(2)-)-methyltransferase, transcript variant X2
probable tRNA (uracil-O(2)-)-methyltransferase, transcript variant X1
probable tRNA (uracil-O(2)-)-methyltransferase
serine protease 33-like, transcript variant X2
serine protease 33-like, transcript variant X4
serine protease 33-like, transcript variant X1
serine protease 33-like, transcript variant X8
serine protease 33-like, transcript variant X7
serine protease 33-like, transcript variant X9
serine protease 33-like, transcript variant X6
serine protease 33-like, transcript variant X5
serine protease 33-like, transcript variant X3
serine proteinase stubble-like isoform X2
putative per-hexamer repeat protein 5, transcript variant X2
putative per-hexamer repeat protein 5, transcript variant X3
putative per-hexamer repeat protein 5, transcript variant X1
putative per-hexamer repeat protein 5 isoform X2
putative per-hexamer repeat protein 5 isoform X3
putative per-hexamer repeat protein 5 isoform X1
catenin alpha-like, transcript variant X5
catenin alpha-like, transcript variant X14
catenin alpha-like, transcript variant X1
catenin alpha-like, transcript variant X10
catenin alpha-like, transcript variant X7
catenin alpha-like, transcript variant X11
catenin alpha-like, transcript variant X3
catenin alpha-like, transcript variant X8
catenin alpha-like, transcript variant X12
catenin alpha-like, transcript variant X4
catenin alpha-like, transcript variant X9
catenin alpha-like, transcript variant X13
catenin alpha-like, transcript variant X6
catenin alpha-like, transcript variant X2
NADPH:adrenodoxin oxidoreductase, mitochondrial-like, transcript variant X1
NADPH:adrenodoxin oxidoreductase, mitochondrial-like, transcript variant X3
NADPH:adrenodoxin oxidoreductase, mitochondrial-like, transcript variant X2
NADPH:adrenodoxin oxidoreductase, mitochondrial-like
periodic tryptophan protein 2 homolog, transcript variant X3
periodic tryptophan protein 2 homolog, transcript variant X1
periodic tryptophan protein 2 homolog, transcript variant X6
periodic tryptophan protein 2 homolog, transcript variant X7
periodic tryptophan protein 2 homolog, transcript variant X5
periodic tryptophan protein 2 homolog, transcript variant X4
periodic tryptophan protein 2 homolog, transcript variant X2
uncharacterized LOC123503400, transcript variant X2
uncharacterized LOC123503400, transcript variant X1
trichohyalin-like, transcript variant X12
trichohyalin-like, transcript variant X10
trichohyalin-like, transcript variant X7
trichohyalin-like, transcript variant X3
trichohyalin-like, transcript variant X8
trichohyalin-like, transcript variant X4
trichohyalin-like, transcript variant X5
trichohyalin-like, transcript variant X2
trichohyalin-like, transcript variant X9
trichohyalin-like, transcript variant X6
trichohyalin-like, transcript variant X1
trichohyalin-like, transcript variant X15
trichohyalin-like, transcript variant X13
trichohyalin-like, transcript variant X14
trichohyalin-like, transcript variant X11
trichohyalin-like, transcript variant X20
trichohyalin-like, transcript variant X18
trichohyalin-like, transcript variant X17
trichohyalin-like, transcript variant X16
trichohyalin-like, transcript variant X21
trichohyalin-like, transcript variant X19
microtubule-associated protein futsch-like isoform X11
microtubule-associated protein futsch-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123503399
uncharacterized LOC123503397, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC123503397, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized protein LOC123503397 isoform X1
uncharacterized protein LOC123503397 isoform X3
uncharacterized protein LOC123503397 isoform X2
DNA repair protein RAD51 homolog A-like, transcript variant X5
DNA repair protein RAD51 homolog A-like, transcript variant X2
DNA repair protein RAD51 homolog A-like, transcript variant X4
DNA repair protein RAD51 homolog A-like, transcript variant X3
DNA repair protein RAD51 homolog A-like, transcript variant X11
DNA repair protein RAD51 homolog A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
DNA repair protein RAD51 homolog A-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 85 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DNA repair protein RAD51 homolog A-like, transcript variant X1
DNA repair protein RAD51 homolog A-like, transcript variant X10
DNA repair protein RAD51 homolog A-like, transcript variant X8
DNA repair protein RAD51 homolog A-like, transcript variant X7
DNA repair protein RAD51 homolog A-like isoform X1
DNA repair protein RAD51 homolog A-like isoform X2
thioredoxin reductase-like selenoprotein T homolog CG3887
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: thioredoxin reductase-like selenoprotein T homolog CG3887
ragulator complex protein LAMTOR1-like, transcript variant X2
ragulator complex protein LAMTOR1-like, transcript variant X1
ragulator complex protein LAMTOR1-like isoform X2
ragulator complex protein LAMTOR1-like isoform X1
CKLF-like MARVEL transmembrane domain-containing protein 4, transcript variant X2
CKLF-like MARVEL transmembrane domain-containing protein 4, transcript variant X1
CKLF-like MARVEL transmembrane domain-containing protein 4, transcript variant X3
CKLF-like MARVEL transmembrane domain-containing protein 4
neural-cadherin-like, transcript variant X4
complex I assembly factor ACAD9, mitochondrial-like
phospholipase DDHD1-like, transcript variant X3
phospholipase DDHD1-like, transcript variant X1
phospholipase DDHD1-like, transcript variant X2
phospholipase DDHD1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123503442
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine/threonine-protein kinase pim-1-like
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine/threonine-protein kinase pim-3-like
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123503699, transcript variant X3
uncharacterized LOC123503699, transcript variant X2
uncharacterized LOC123503699, transcript variant X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit-like, transcript variant X3
N-alpha-acetyltransferase 35, NatC auxiliary subunit-like, transcript variant X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit-like, transcript variant X2
N-alpha-acetyltransferase 35, NatC auxiliary subunit-like isoform X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit-like isoform X2
neuropeptide F receptor-like, transcript variant X2
neuropeptide F receptor-like, transcript variant X1
uncharacterized LOC123503863, transcript variant X2
uncharacterized LOC123503863, transcript variant X6
uncharacterized LOC123503863, transcript variant X3
uncharacterized protein LOC123503863 isoform X2
uncharacterized LOC123503863, transcript variant X16
uncharacterized LOC123503863, transcript variant X18
uncharacterized LOC123503863, transcript variant X12
uncharacterized LOC123503863, transcript variant X17
uncharacterized LOC123503863, transcript variant X4
uncharacterized LOC123503863, transcript variant X5
uncharacterized LOC123503863, transcript variant X1
uncharacterized LOC123503863, transcript variant X13
uncharacterized LOC123503863, transcript variant X7
uncharacterized LOC123503863, transcript variant X8
uncharacterized LOC123503863, transcript variant X14
uncharacterized protein LOC123503863 isoform X6
uncharacterized protein LOC123503863 isoform X1
uncharacterized protein LOC123503863 isoform X5
uncharacterized protein LOC123503863 isoform X3
uncharacterized protein LOC123503863 isoform X4
uncharacterized LOC123503863, transcript variant X11
uncharacterized LOC123503863, transcript variant X15
uncharacterized LOC123503863, transcript variant X9
uncharacterized LOC123503863, transcript variant X10
uncharacterized protein LOC123503863 isoform X7
uncharacterized protein LOC123503863 isoform X8
probable small nuclear ribonucleoprotein E
PDZ domain-containing protein 11-like, transcript variant X1
PDZ domain-containing protein 11-like, transcript variant X2
PDZ domain-containing protein 11-like isoform X2
PDZ domain-containing protein 11-like isoform X1
probable ATP-dependent RNA helicase DDX17, transcript variant X5
probable ATP-dependent RNA helicase DDX17, transcript variant X6
probable ATP-dependent RNA helicase DDX17, transcript variant X4
probable ATP-dependent RNA helicase DDX17, transcript variant X3
probable ATP-dependent RNA helicase DDX17, transcript variant X7
probable ATP-dependent RNA helicase DDX17, transcript variant X1
probable ATP-dependent RNA helicase DDX17, transcript variant X2
probable ATP-dependent RNA helicase DDX17 isoform X7
ATP-dependent RNA helicase dbp2-like isoform X5
ATP-dependent RNA helicase dbp2-like isoform X6
ATP-dependent RNA helicase dbp2-like isoform X4
ATP-dependent RNA helicase dbp2-like isoform X3
ATP-dependent RNA helicase dbp2-like isoform X1
ATP-dependent RNA helicase dbp2-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 142-like
mediator of DNA damage checkpoint protein 1-like
GPN-loop GTPase 2-like, transcript variant X1
GPN-loop GTPase 2-like, transcript variant X2
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform-like isoform X1
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform-like isoform X2
probable diaminopimelate decarboxylase, chloroplastic, transcript variant X2
probable diaminopimelate decarboxylase, chloroplastic, transcript variant X1
probable diaminopimelate decarboxylase, chloroplastic isoform X2
probable diaminopimelate decarboxylase, chloroplastic isoform X1
39S ribosomal protein L4, mitochondrial-like, transcript variant X1
39S ribosomal protein L4, mitochondrial-like, transcript variant X2
39S ribosomal protein L4, mitochondrial-like
alpha-mannosidase 2-like, transcript variant X2
alpha-mannosidase 2-like, transcript variant X4
alpha-mannosidase 2-like, transcript variant X1
alpha-mannosidase 2-like, transcript variant X3
alpha-mannosidase 2-like, transcript variant X5
uncharacterized LOC123503643, transcript variant X2
uncharacterized LOC123503643, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
microspherule protein 1-like, transcript variant X4
microspherule protein 1-like, transcript variant X3
microspherule protein 1-like, transcript variant X1
microspherule protein 1-like, transcript variant X2
maternal embryonic leucine zipper kinase-like, transcript variant X1
maternal embryonic leucine zipper kinase-like, transcript variant X2
maternal embryonic leucine zipper kinase-like isoform X1
maternal embryonic leucine zipper kinase-like isoform X2
methylenetetrahydrofolate reductase-like, transcript variant X1
methylenetetrahydrofolate reductase-like, transcript variant X2
methylenetetrahydrofolate reductase-like
USP6 N-terminal-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
USP6 N-terminal-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
USP6 N-terminal-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
USP6 N-terminal-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized protein LOC123503607 isoform X1
TBC domain-containing protein C215.01-like isoform X2
signal transducing adapter molecule 1-like
phosphate carrier protein, mitochondrial-like
LOW QUALITY PROTEIN: serine-rich adhesin for platelets-like
ras-related protein Rap-1b, transcript variant X4
ras-related protein Rap-1b, transcript variant X1
ras-related protein Rap-1b, transcript variant X2
ras-related protein Rap-1b, transcript variant X3
DNA-directed RNA polymerase I subunit rpa49-like
band 3 anion transport protein-like, transcript variant X4
band 3 anion transport protein-like, transcript variant X1
band 3 anion transport protein-like, transcript variant X3
band 3 anion transport protein-like, transcript variant X2
band 3 anion transport protein-like, transcript variant X5
band 3 anion transport protein-like isoform X3
band 3 anion transport protein-like isoform X2
band 3 anion transport protein-like isoform X4
band 3 anion transport protein-like isoform X1
band 3 anion transport protein-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
squamous cell carcinoma antigen recognized by T-cells 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Werner syndrome ATP-dependent helicase homolog
peptidyl-prolyl cis-trans isomerase Fkbp12-like
polypeptide N-acetylgalactosaminyltransferase 11-like, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 11-like, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 11-like isoform X1
polypeptide N-acetylgalactosaminyltransferase 11-like isoform X2
ATPase family AAA domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATPase family AAA domain-containing protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ATPase family AAA domain-containing protein 2-like, transcript variant X2
ATPase family AAA domain-containing protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ATPase family AAA domain-containing protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ATPase family AAA domain-containing protein 2-like isoform X1
ATPase family AAA domain-containing protein 2-like isoform X3
ATPase family AAA domain-containing protein 2-like isoform X2
ATPase family AAA domain-containing protein 2-like isoform X4
ATPase family AAA domain-containing protein 2-like isoform X5
tigger transposable element-derived protein 4-like, transcript variant X3
tigger transposable element-derived protein 4-like, transcript variant X2
tigger transposable element-derived protein 4-like, transcript variant X1
tigger transposable element-derived protein 4-like
histone-lysine N-methyltransferase SETD1B-A-like, transcript variant X2
histone-lysine N-methyltransferase SETD1B-A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized protein LOC123503355 isoform X2
histone-lysine N-methyltransferase SETD1B-A-like isoform X1
probable 28S rRNA (cytosine-C(5))-methyltransferase
DNA (cytosine-5)-methyltransferase 3A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 97-like
LOW QUALITY PROTEIN: coiled-coil domain-containing protein 97-like
zinc finger HIT domain-containing protein 1-like, transcript variant X2
zinc finger HIT domain-containing protein 1-like, transcript variant X1
zinc finger HIT domain-containing protein 1-like
serine/threonine/tyrosine-interacting protein B-like, transcript variant X2
serine/threonine/tyrosine-interacting protein B-like, transcript variant X1
serine/threonine/tyrosine-interacting protein B-like, transcript variant X4
serine/threonine/tyrosine-interacting protein B-like, transcript variant X3
serine/threonine/tyrosine-interacting protein B-like isoform X2
serine/threonine/tyrosine-interacting protein B-like isoform X1
serine/threonine/tyrosine-interacting protein B-like isoform X4
serine/threonine/tyrosine-interacting protein B-like isoform X3
LOW QUALITY PROTEIN: guanine deaminase-like
uncharacterized LOC123503682, transcript variant X2
protein APCDD1-like, transcript variant X2
protein APCDD1-like, transcript variant X1
uncharacterized LOC123503682, transcript variant X1
retinoblastoma-like protein 1, transcript variant X1
retinoblastoma-like protein 1 isoform X1
retinoblastoma-like protein 1, transcript variant X2
retinoblastoma-like protein 1 isoform X2
putative peptidyl-prolyl cis-trans isomerase dodo
uncharacterized LOC123503642, transcript variant X1
uncharacterized LOC123503642, transcript variant X2
uncharacterized protein LOC123503642 isoform X1
uncharacterized protein LOC123503642 isoform X2
LOW QUALITY PROTEIN: neuroligin-4, X-linked-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
synaptic vesicle glycoprotein 2C-like, transcript variant X2
synaptic vesicle glycoprotein 2C-like, transcript variant X1
CTD small phosphatase-like protein 2-A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A isoform X3
CTD small phosphatase-like protein 2-A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A, transcript variant X8
CTD small phosphatase-like protein 2-A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A isoform X1
CTD small phosphatase-like protein 2-A isoform X2
CTD small phosphatase-like protein 2-A, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
CTD small phosphatase-like protein 2-A, transcript variant X4
CTD small phosphatase-like protein 2-A isoform X4
CTD small phosphatase-like protein 2-A isoform X5
phosphoinositide 3-kinase regulatory subunit 4-like
aldo-keto reductase family 1 member B1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
cytoplasmic tRNA 2-thiolation protein 2-A-like
insulin receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
insulin receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
doublesex- and mab-3-related transcription factor A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
carbohydrate sulfotransferase 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
carbohydrate sulfotransferase 11-like, transcript variant X2
carbohydrate sulfotransferase 11-like, transcript variant X3
carbohydrate sulfotransferase 8-like isoform X2
carbohydrate sulfotransferase 11-like isoform X1
carbohydrate sulfotransferase 11-like isoform X3
signal peptide peptidase-like 3, transcript variant X1
signal peptide peptidase-like 3, transcript variant X2
signal peptide peptidase-like 3 isoform X1
signal peptide peptidase-like 3, transcript variant X3
signal peptide peptidase-like 3, transcript variant X4
signal peptide peptidase-like 3 isoform X3
signal peptide peptidase-like 3 isoform X2
organic cation transporter protein-like, transcript variant X3
organic cation transporter protein-like, transcript variant X4
organic cation transporter protein-like, transcript variant X2
organic cation transporter protein-like, transcript variant X1
organic cation transporter protein-like isoform X2
organic cation transporter 1-like isoform X1
organic cation transporter 1-like isoform X3
nucleoporin NSP1-like, transcript variant X2
nucleoporin NSP1-like, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123503857
casein kinase II subunit beta, transcript variant X2
casein kinase II subunit beta, transcript variant X1
casein kinase II subunit beta isoform X2
casein kinase II subunit beta isoform X1
BAI1-associated protein 3-like, transcript variant X1
BAI1-associated protein 3-like, transcript variant X3
BAI1-associated protein 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BAI1-associated protein 3-like, transcript variant X2
BAI1-associated protein 3-like isoform X1
BAI1-associated protein 3-like isoform X2
BAI1-associated protein 3-like isoform X3
ATP synthase subunit gamma, mitochondrial-like
DNA repair protein XRCC1-like, transcript variant X2
DNA repair protein XRCC1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
DNA repair protein XRCC1-like isoform X2
DNA repair protein XRCC1-like isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
charged multivesicular body protein 1a-like
chromatin modification-related protein eaf-1-like, transcript variant X4
chromatin modification-related protein eaf-1-like, transcript variant X1
chromatin modification-related protein eaf-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromatin modification-related protein eaf-1-like, transcript variant X2
chromatin modification-related protein eaf-1-like
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X20
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X19
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X11
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X18
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X8
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X7
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X13
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X17
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X12
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X15
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X9
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X14
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X16
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X10
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X7
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X8
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X9
nucleoporin p58/p45-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
nucleoporin p58/p45-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
nucleoporin p58/p45-like, transcript variant X5
nucleoporin p58/p45-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
nucleoporin p58/p45-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
nucleoporin p58/p45-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like, transcript variant X3
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like, transcript variant X1
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like isoform X1
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like, transcript variant X2
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like, transcript variant X5
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like, transcript variant X4
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like, transcript variant X6
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]-like isoform X2
glutaminyl-peptide cyclotransferase-like, transcript variant X1
glutaminyl-peptide cyclotransferase-like isoform X1
glutaminyl-peptide cyclotransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC123503803 isoform X2
TATA element modulatory factor-like, transcript variant X2
TATA element modulatory factor-like, transcript variant X3
TATA element modulatory factor-like, transcript variant X4
TATA element modulatory factor-like, transcript variant X1
TATA element modulatory factor-like, transcript variant X6
TATA element modulatory factor-like, transcript variant X5
TATA element modulatory factor-like isoform X2
TATA element modulatory factor-like isoform X3
TATA element modulatory factor-like isoform X4
TATA element modulatory factor-like isoform X1
TATA element modulatory factor-like isoform X5
G-protein coupled receptor dmsr-1-like, transcript variant X1
G-protein coupled receptor dmsr-1-like, transcript variant X2
G-protein coupled receptor dmsr-1-like isoform X2
G-protein coupled receptor dmsr-1-like isoform X1
uncharacterized LOC123503810, transcript variant X1
uncharacterized LOC123503810, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X5
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X6
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like, transcript variant X7
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X7
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X6
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X5
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II-like isoform X1
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase HUWE1-like
DNA-directed RNA polymerases I and III subunit RPAC2-like, transcript variant X2
DNA-directed RNA polymerases I and III subunit RPAC2-like, transcript variant X1
DNA-directed RNA polymerases I and III subunit RPAC2-like
uncharacterized LOC123503816, transcript variant X1
uncharacterized protein LOC123503816 isoform X1
uncharacterized LOC123503816, transcript variant X2
uncharacterized protein LOC123503816 isoform X2
zinc finger and BTB domain-containing protein 7A-like, transcript variant X2
zinc finger and BTB domain-containing protein 7A-like, transcript variant X1
zinc finger and BTB domain-containing protein 7A-like, transcript variant X3
zinc finger and BTB domain-containing protein 7A-like, transcript variant X4
zinc finger and BTB domain-containing protein 7A-like isoform X1
zinc finger and BTB domain-containing protein 7A-like isoform X2
S phase cyclin A-associated protein in the endoplasmic reticulum-like, transcript variant X6
bifunctional protein GlmU-like, transcript variant X4
bifunctional protein GlmU-like, transcript variant X3
bifunctional protein GlmU-like, transcript variant X5
bifunctional protein GlmU-like, transcript variant X2
bifunctional protein GlmU-like, transcript variant X1
uncharacterized protein LOC123503821 isoform X2
bifunctional protein GlmU-like isoform X1
S phase cyclin A-associated protein in the endoplasmic reticulum-like, transcript variant X2
S phase cyclin A-associated protein in the endoplasmic reticulum-like, transcript variant X1
S phase cyclin A-associated protein in the endoplasmic reticulum-like, transcript variant X3
S phase cyclin A-associated protein in the endoplasmic reticulum-like, transcript variant X4
S phase cyclin A-associated protein in the endoplasmic reticulum-like isoform X1
S phase cyclin A-associated protein in the endoplasmic reticulum-like, transcript variant X5
S phase cyclin A-associated protein in the endoplasmic reticulum-like isoform X2
translation initiation factor eIF-2B subunit beta-like
ribosomal protein S6 kinase alpha-5-like, transcript variant X6
ribosomal protein S6 kinase alpha-5-like, transcript variant X5
ribosomal protein S6 kinase alpha-5-like, transcript variant X4
ribosomal protein S6 kinase alpha-5-like, transcript variant X7
ribosomal protein S6 kinase alpha-5-like, transcript variant X3
ribosomal protein S6 kinase alpha-5-like, transcript variant X1
ribosomal protein S6 kinase alpha-5-like, transcript variant X2
ribosomal protein S6 kinase alpha-5-like isoform X2
ribosomal protein S6 kinase alpha-5-like isoform X4
ribosomal protein S6 kinase alpha-5-like isoform X1
ribosomal protein S6 kinase alpha-5-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X4
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X7
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X10
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X6
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X5
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X13
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X2
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X1
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X8
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X16
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X9
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X14
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X11
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X15
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X18
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X12
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X17
aryl hydrocarbon receptor nuclear translocator homolog, transcript variant X3
aryl hydrocarbon receptor nuclear translocator homolog isoform X1
aryl hydrocarbon receptor nuclear translocator homolog isoform X3
aryl hydrocarbon receptor nuclear translocator homolog isoform X2
aryl hydrocarbon receptor nuclear translocator homolog isoform X4
aryl hydrocarbon receptor nuclear translocator homolog isoform X5
aryl hydrocarbon receptor nuclear translocator homolog isoform X9
aryl hydrocarbon receptor nuclear translocator homolog isoform X10
aryl hydrocarbon receptor nuclear translocator homolog isoform X11
aryl hydrocarbon receptor nuclear translocator homolog isoform X8
aryl hydrocarbon receptor nuclear translocator homolog isoform X13
aryl hydrocarbon receptor nuclear translocator homolog isoform X6
aryl hydrocarbon receptor nuclear translocator homolog isoform X7
aryl hydrocarbon receptor nuclear translocator homolog isoform X12
aryl hydrocarbon receptor nuclear translocator homolog isoform X14
aryl hydrocarbon receptor nuclear translocator homolog isoform X15
zinc finger protein chinmo-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein chinmo-like, transcript variant X3
zinc finger protein chinmo-like, transcript variant X4
zinc finger protein chinmo-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein chinmo-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein chinmo-like, transcript variant X1
zinc finger protein chinmo-like, transcript variant X10
zinc finger protein chinmo-like isoform X8
zinc finger protein chinmo-like, transcript variant X9
zinc finger protein chinmo-like, transcript variant X6
zinc finger protein chinmo-like, transcript variant X8
estradiol 17-beta-dehydrogenase 8-like, transcript variant X4
estradiol 17-beta-dehydrogenase 8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
estradiol 17-beta-dehydrogenase 8-like, transcript variant X2
estradiol 17-beta-dehydrogenase 8-like, transcript variant X1
estradiol 17-beta-dehydrogenase 8-like isoform X1
estradiol 17-beta-dehydrogenase 8-like isoform X2
unconventional myosin IC-like, transcript variant X3
unconventional myosin IC-like, transcript variant X2
unconventional myosin IC-like isoform X2
unconventional myosin IC-like, transcript variant X1
unconventional myosin IC-like isoform X1
unconventional myosin IC-like isoform X3
uncharacterized LOC123503393, transcript variant X1
uncharacterized LOC123503393, transcript variant X5
uncharacterized LOC123503393, transcript variant X7
uncharacterized LOC123503393, transcript variant X4
uncharacterized LOC123503393, transcript variant X3
uncharacterized LOC123503393, transcript variant X8
uncharacterized LOC123503393, transcript variant X2
uncharacterized LOC123503393, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
uncharacterized LOC123503710, transcript variant X3
uncharacterized LOC123503710, transcript variant X1
uncharacterized LOC123503710, transcript variant X2